Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Dou, Liping  [Clear All Filters]
2024
Ma C, Chen P, Du J, Wang L, Lu N, Sun J, Qilong X, Wang Y, Dou L, Liu D-H. Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation. J Immunother Cancer. 2024;12(1).
Gu Z, Li F, Li M, Wang L, Lu N, Jin X, Wang L, Gao C, Dou L, Liu D. Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study. Ann Hematol. 2024.
2023
Xu Y, Wei Y, Wang L, Lu N, Wu Y, Dou L, Liu D, Li M, Gao C. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange. Ann Transplant. 2023;28:e939890.
Wang H, Wang N, Wang L, Du J, Li F, Shao Y, Peng B, Luan S, Wang L, Jin X, et al. Targeted dosing of anti-thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single-arm, phase 2 trial. Am J Hematol. 2023.
2022
Wang N, Wang H, Fang S, Du J, Huang S, Li F, Jin X, Jia M, Xu L, Dou L, et al. High Risk of Recurrence of Malignancy Noted in 4-day rATG Regimen after Allogeneic PBSCT from Matched Sibling Donors. Transplant Cell Ther. 2022.
Gu Z, Xiong Q, Wang L, Wang L, Li F, Hou C, Dou L, Zhu B, Liu D. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation. Cancer. 2022.
2021
Zhang R, Wang L, Chen P, Gao X, Wang S, Li F, Dou L, Gao C, Li Y, Liu D. Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study. Cancer Med. 2021.
2020
Hou C, Dou L, Jia M, Li F, Wang S, Gao X, Wang L, Jin X, Wang L, Gao C, et al. Ruxolitinib Combined with Corticosteroids as First-line Therapy for Acute Graft Versus Host Disease in Haploidentical Peripheral Blood Stem Cell Transplant Patients. Biol Blood Marrow Transplant. 2020.
2015
Li D, Wang L, Zhu H, Dou L, Liu D, Fu L, Ma C, Ma X, Yao Y, Zhou L, et al. Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies. PLoS One. 2015;10(7):e0132620.